Navigation Links
Delcath Signs Agreement With Synerx and Mylan's Bioniche Teoranta for Melphalan Supply
Date:10/14/2010

urrent or future drug–delivery system for the treatment of other liver cancers and other organs, the potential of chemosaturation therapy via PHP as a treatment for patients with terminal metastatic disease in the liver, actions by the FDA or other regulatory agencies, our ability to successfully enter into distribution and strategic partnership agreements in foreign markets and the corresponding revenue associated with such foreign markets, and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward–looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward–looking statements to reflect events or circumstances after the date they are made.


'/>"/>
SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , 7 de julio de 2015 /PRNewswire/ ... de propiedad privada centrada en el desarrollo de ... neurovascular, ha anunciado hoy que R. Michael ... directiva. Kleine cuenta con más ... de los dispositivos médicos y la sanidad. Ha ...
(Date:7/7/2015)... , July 7, 2015 According ... by Method (Manual, Automated), Product (Consumables, Instrument), Application (Aerobic, Anaerobic, ... Academic Research Institute) - Forecast to 2019", published by MarketsandMarkets, ... $3,893.5 Million by 2019 from $2,750.2 Million in 2014 at ... 1 78 ma rket ...
(Date:7/7/2015)... Md. , July 7, 2015 ... (CRO) focusing in Oncology, Vaccines, and General Medicine ... the final locked database to Heron Therapeutics, Inc. ... 3 receptor antagonist product candidate SUSTOL® (granisetron ... regimen with the IV NK 1 receptor ...
Breaking Medicine Technology:Sequent Medical nombra a Mike Kleine a su junta directiva 2Sequent Medical nombra a Mike Kleine a su junta directiva 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 2Blood Culture Tests Market Worth $3,893.5 Million by 2019 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 4Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... Supreme Court decision in Pliva v. Mensing is ... legal immunity when they ignore harmful side-effects of the drugs ... for generic manufacturers to ensure their drug is safe and ... This decision also means that brand-name manufacturers will be held ...
... Ill., June 23, 2011 Akorn, Inc. (NASDAQ: ... Tuesday, August 2, 2011, to discuss second quarter 2011 ... the same day before the market opens. Subject: , ... 2, 2011, at 10:00 a.m. Eastern TimeDomestic Callers: , ...
Cached Medicine Technology:Generic Drug Decision Disastrous to Patient Safety 2
(Date:7/7/2015)... ... July 07, 2015 , ... Dr. Poneh Ghasri , cosmetic dentist ... professional teeth whitening is one of the fastest, easiest ways to brighten a smile. ... decrease smile satisfaction and confidence. With the right teeth whitening treatment, patients can restore ...
(Date:7/7/2015)... ... July 07, 2015 , ... America is blessed with people who continually ... Hero program offers a special way to say “thanks.” Give them the recognition ... gift card and their place on the “Wall of Heroes.” , “We hear ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... executive Ellen Purdy as the company’s new Chief Financial Officer, effective July 6th, ... leadership experience in companies ranging from a multi-billion dollar, global chemical company to ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... with strong managerial expertise to oversee large healthcare operations and their success ... business partners, insurance companies, and regulators. American Sentinel University, an innovative, accredited ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... provider of unified communication management solutions, has announced the release of Service ... This service pack includes a number of enhancements to the already robust ...
Breaking Medicine News(10 mins):Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3Health News:California Casualty Wants to Know: "Who Is Your Hero?" 2Health News:Office Practicum Announces new CFO 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2
... ARBOR, Mich., Nov. 5 University of,Michigan executive ... passage of Proposal 2, the amendment to the ... to be derived from,embryos that have been created ... amendment would otherwise be discarded, unless,donated with informed ...
... study finds , , TUESDAY, Nov. 4 (HealthDay News) -- ... can raise the long term risk of death for ... , Surviving a heart attack or cardiac arrest ... later develop PTSD, which includes intense anxiety, flashbacks and ...
... - Conference Call Today at 9:00 a.m. EST -, ... MNKD ) today reported financial results for the third ... of 2008, total operating expenses were $69.1,million, compared to ... to the $9.2 million reduction in research and development,(R&D) ...
... Outpatient Services Are a Leading Factor for,Consolidation, ... NASHVILLE, Tenn., Nov. 5 HealthLeaders-InterStudy, a,leading ... that health,system expansion efforts in the Charleston, ... among local physician groups. According to the ...
... symptoms in half for passengers taking 7- to ... ... in the,journal of Minerva Cardioangiologica reveals Pycnogenol(R), pine bark,extract from the French ... study, consisting of a brain CT scan and a,scoring system, showed Pycnogenol(R) ...
... 5 BD (Becton,Dickinson and Company) (NYSE: BDX ... fourth fiscal quarter ended September 30, 2008,representing an increase ... growth rate reflects the favorable impact on all segments ... for 5,percentage points of the increase in quarterly revenues., ...
Cached Medicine News:Health News:The University of Michigan Welcomes Passage of Proposal 2 2Health News:The University of Michigan Welcomes Passage of Proposal 2 3Health News:The University of Michigan Welcomes Passage of Proposal 2 4Health News:Anxiety Linked to Heart Attack Can Raise Death Risk 2Health News:MannKind Corporation Reports Third Quarter Financial Results 2Health News:MannKind Corporation Reports Third Quarter Financial Results 3Health News:MannKind Corporation Reports Third Quarter Financial Results 4Health News:MannKind Corporation Reports Third Quarter Financial Results 5Health News:MannKind Corporation Reports Third Quarter Financial Results 6Health News:MannKind Corporation Reports Third Quarter Financial Results 7Health News:MannKind Corporation Reports Third Quarter Financial Results 8Health News:Charleston, S.C., Market Integration Likely to Drive Physician Groups to Seek Health System Affiliation 2Health News:Charleston, S.C., Market Integration Likely to Drive Physician Groups to Seek Health System Affiliation 3Health News:Study Shows Pine Bark Reduces Jetlag 2Health News:Study Shows Pine Bark Reduces Jetlag 3Health News:Study Shows Pine Bark Reduces Jetlag 4Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 2Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 3Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 4Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 5Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 6Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 7Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 8Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 9Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 10Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 11Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 12Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 13Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 14
... immunofluorescent antibody (IFA) test ... semi-quantitation of human serum ... viral capsid antigen (VCA). ... 12-well slides, FITC IgG ...
CMF OL1000 Bone Growth Stimulators are portable, battery-powered medical devices indicated for use in the noninvasive treatment of an established nonunion fracture acquired secondary to trauma, exclu...
... bone growth stimulator for the treatment of ... bone growth stimulator is a useful adjunct ... is already planned or when patient compliance ... is totally surgically implanted, patients are assured ...
... Stryker is proud to ... resectoscopes on the market at ... ergonomic design incorporates a superior ... and intuitive locking mechanisms. The ...
Medicine Products: